Expanding US Outpatient Services Will Meet Evolving Healthcare Demands

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

20 Jul 25

Updated

29 Nov 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-45.9%

7D

-2.7%

Loading

1Y

-45.9%

7D

-2.7%

You can edit this narrative until Nov 30 7:10 PM. Then, changes will post as Updates.

Author's Valuation

US$13.9636.4% undervalued

AnalystConsensusTarget Fair Value

Shared on 29 Nov 25

Fair value Decreased 11%

ARDT: Margin Pressures Will Ease As Cost Programs Improve Efficiency

Ardent Health's analyst price target has been lowered from approximately $15.62 to $13.96. Analysts cite persistent margin pressures, elevated professional fees, and ongoing payer denials as contributing factors, despite continued strength in demand and sales growth potential.

Shared on 15 Nov 25

Fair value Decreased 18%

ARDT: Margin Initiatives Will Drive Share Recovery Despite Persistent Cost Headwinds

Ardent Health's fair value estimate has been revised down from $19.08 to $15.62. Analysts cite ongoing cost pressures, weaker guidance, and concerns over revenue growth as key factors behind the lower price targets.

Shared on 11 Sep 25

Fair value Decreased 0.98%

With both Ardent Health’s future P/E and consensus revenue growth forecasts holding steady, analysts have made only a marginal downward revision in their fair value estimate, lowering the price target from $19.27 to $19.08. What's in the News Ardent Health reaffirmed full-year 2025 earnings guidance, projecting total revenue between $6.2 billion and $6.45 billion and diluted EPS in the range of $1.73 to $2.01.

AnalystConsensusTarget Fair Value

US$13.96

36.4% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

4.97%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

8.34%

Calculation

US$241.76m

Earnings '28

x

10.58x

PE Ratio '28

=

US$2.56b

Market Cap '28

US$2.56b

Market Cap '28

/

144.51m

No. shares '28

=

US$17.70

Share Price '28

US$17.70 Share Price '28

Discounted to 2025 @ 8.36% p.a.

=

US$13.91

Fair Value '25